Skip to main content
Explore URMC
URMC / Research / Clinical Trials / Study Details

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

Research Question:
Does guselkumab help patients with Crohn's disease?

Basic Study Information

The purpose of this program is to evaluate the efficacy and safety of guselkumab (an injection under the skin) in participants with Crohn's disease. Inclusion Criteria: Have Crohn's disease or fistulizing Crohn's disease for at least 3 months duration (a minimum of 12 weeks). Have demonstrated intolerance or inadequate response to conventional or biologic therapy for Chrohn's disease.

Location: University of Rochester Medical Center

Lead Researcher (Principal Investigator)

Lead Researcher:  Lawrence Saubermann

Study Contact Information

Study Coordinator: Study Contact
Phone: (844) 434-4210

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search